Kwality Pharmaceuticals Limited — Imipenem Exporter Profile
Indian Pharmaceutical Exporter · #9 for Imipenem · $324.4K export value · DGFT Verified
Kwality Pharmaceuticals Limited is the #9 Indian exporter of Imipenem with $324.4K in export value and 18 verified shipments. Kwality Pharmaceuticals Limited holds a 1.0% market share in Imipenem exports across 4 countries. The company exports 20 pharmaceutical products worth $5.6M across 11 therapeutic categories.
Kwality Pharmaceuticals Limited — Imipenem Export Profile: Buyers & Destinations
Where Does Kwality Pharmaceuticals Limited Export Imipenem?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BOLIVIA | $232.4K | 7 | 77.9% |
| TURKEY | $38.7K | 4 | 13.0% |
| NIGERIA | $18.9K | 6 | 6.3% |
| MYANMAR | $8.5K | 1 | 2.9% |
Kwality Pharmaceuticals Limited exports Imipenem to 4 countries. The largest destination is BOLIVIA accounting for 77.9% of Kwality Pharmaceuticals Limited's Imipenem shipments, followed by TURKEY (13.0%) and NIGERIA (6.3%). These destinations reflect Kwality Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Imipenem from Kwality Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CALLE COCHABAMBA | BOLIVIA | $112.7K | 3 |
| LOBA IMPORT EXPORT SRL | BOLIVIA | $50.0K | 1 |
| LANA GRUP ITHALAT IHRACAT TICARET V | TURKEY | $38.7K | 4 |
| CALLE COCHABAMBA 579 | BOLIVIA | $35.3K | 1 |
| LOBA IMPORT EXPORT CALLE COCHABAMBA | BOLIVIA | $34.5K | 2 |
| DOMAKS INVESTMENT LIMITED | NIGERIA | $13.2K | 4 |
| DIRECTORATE OF PROCUREMENT | MYANMAR | $8.5K | 1 |
| DOMAKS INVESTMENT LTD | NIGERIA | $2.9K | 1 |
| MERRITT GLOBAL LTD | NIGERIA | $2.8K | 1 |
Kwality Pharmaceuticals Limited supplies Imipenem to 9 buyers globally. The largest buyer is CALLE COCHABAMBA (BOLIVIA), followed by LOBA IMPORT EXPORT SRL (BOLIVIA) and LANA GRUP ITHALAT IHRACAT TICARET V (TURKEY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Imipenem Export Value and How Much Does Kwality Pharmaceuticals Limited Contribute?
India exported $20.1M worth of Imipenem through 803 shipments from 140 suppliers to 94 countries, serving 302 buyers globally. Kwality Pharmaceuticals Limited contributes $324.4K to this total, accounting for 1.0% of India's Imipenem exports. Kwality Pharmaceuticals Limited ships Imipenem to 4 countries through 9 buyers.
What Is the Average Shipment Value for Kwality Pharmaceuticals Limited's Imipenem Exports?
Kwality Pharmaceuticals Limited's average Imipenem shipment value is $18.0K per consignment, based on 18 shipments totaling $324.4K. The largest destination is BOLIVIA (77.9% of Kwality Pharmaceuticals Limited's Imipenem exports).
How Does Kwality Pharmaceuticals Limited Compare to Other Indian Imipenem Exporters?
Kwality Pharmaceuticals Limited ranks #9 among 140 Indian Imipenem exporters with a 1.0% market share. The top 3 exporters are VENUS REMEDIES LIMITED ($9.7M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($6.0M), PROTECH BIO SYSTEMS PRIVATE LIMITED ($950.0K). Kwality Pharmaceuticals Limited processed 18 shipments to 4 destination countries.
What Imipenem Formulations Does Kwality Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINES FOR HUMAN USE. IMIPENEM AND CILASTATIN FOR INJECTION. BT NO:BI537, MFG: 01/2025, EXP: 12/2027 | $50.0K | 1 |
| HARMLESS MEDICINES FOR HUMAN USE IMIPENEM AND CILASTATIN FOR INJECTION BATCHNO BI639 MFG 04 2025 EXP DT 03 2028 | $50.0K | 1 |
| Imipenem and Cilastatin for Injection (BATCH NO & OTHER DETAILS AS PER INV & PACKING LIST) | $38.7K | 4 |
| IMIPENEM AND CILASTATIN FOR INJECTION (500MG) BATCH NO: BI261 , MFG: 12/2023,EXPDT : 11/2026 (15000 X 1) | $35.3K | 1 |
| IMIPENEM AND CILASTATIN FOR INJ.(ANHYDROUS IMIPENEM 500MGANHYDROUS CILASTATIN 500MG)B#BI308MFG:05/24EXP.04/27(16500X1 | $34.7K | 1 |
| IMIPENEM AND CILASTATIN FOR INJ.ANHYDROUS IMIPENEM 500MGANHYDROUS CILASTATIN 500MGB#BI164 MANUFACTURING :08/23EXP.07/267200X1 | $34.5K | 2 |
| Harmless Medicines for Human use -Imipenem and Cilastatin for Injection Other Details As Per DOCUMENT | $28.0K | 1 |
| IMIPENEM AND CILASTATIN FOR INJECTION USP BATCH NO OTHER DETAIL AS PER INV PACKING LIST | $13.2K | 3 |
| IMIPENEM AND CILASTATIN FOR INJECTION US | $8.5K | 2 |
| Imipenem and Cilastatin for Injection USP (BATCH NO & OTHER DETAIL AS PER INV &PACKING LIST) | $2.9K | 1 |
Kwality Pharmaceuticals Limited exports 11 distinct Imipenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINES FOR HUMAN USE. IMIPENEM AND CILASTATIN FO with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Imipenem to Key Markets
What Kwality Pharmaceuticals Limited must comply with to export Imipenem to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Kwality Pharmaceuticals Limited Compare to Nearest Imipenem Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | M J BIOPHARM PRIVATE LIMITED | $450.0K | 9 | 2 | $50.0K |
| 7 | VEXXA LIFESCIENCES PVT. LTD. | $348.2K | 38 | 3 | $9.2K |
| 9 | KWALITY PHARMACEUTICALS LIMITED ★ | $324.4K | 18 | 4 | $18.0K |
| 10 | MARKSANS PHARMA LIMITED | $236.5K | 8 | 1 | $29.6K |
| 11 | M. J. BIOPHARM PRIVATE LIMITED | $228.9K | 9 | 3 | $25.4K |
Kwality Pharmaceuticals Limited ranks #9 among 140 Indian Imipenem exporters. Average shipment value of $18.0K compared to the market average of $143.4K. The closest competitors by value are M J BIOPHARM PRIVATE LIMITED and VEXXA LIFESCIENCES PVT. LTD..
Which Indian Ports Ship Imipenem Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 114 | 14.2% |
| DELHI AIR | 83 | 10.3% |
| SAHAR AIR | 76 | 9.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 57 | 7.1% |
| NHAVA SHEVA SEA (INNSA1) | 37 | 4.6% |
| Delhi Air | 34 | 4.2% |
| DHANNAD ICD | 30 | 3.7% |
| DHANNAD ICD (INDHA6) | 27 | 3.4% |
What Other Advanced Antibiotics Products Does Kwality Pharmaceuticals Limited Export?
Kwality Pharmaceuticals Limited also exports these advanced antibiotics products. Each links to the detailed product page.
About Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Limited exports 20 products worth $5.6M. Beyond Imipenem, top products include Caffeine, Hydrocortisone, Docetaxel, Amikacin, Cyclophosphamide. View the complete Kwality Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Imipenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Imipenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Kwality Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 18 individual customs records matching Kwality Pharmaceuticals Limited exporting Imipenem, covering 11 formulations to 4 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 302+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Imipenem Export Data from Kwality Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kwality Pharmaceuticals Limited's Imipenem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kwality Pharmaceuticals Limited
Full Company Profile →
20 products · $5.6M total trade · 11 categories
Imipenem Stats
Company Overview
Top Products by Kwality Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Kwality Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Imipenem. For current shipment-level data, contact TransData Nexus.